Close Menu

Vaccine Authorization

The UK has given emergency authorization for the SARS-CoV-2 vaccine from Pfizer and BioNTech, the Associated Press reports.

The firms announced last month that data from their late-stage clinical trial indicated their mRNA-based candidate vaccine has a 95 percent efficacy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.